Clinical development of CAR T cells—challenges and opportunities in translating innovative treatment concepts | EMBO Molecular Medicine
B cell targeting in CAR T cell therapy: Side effect or driver of CAR T cell function? | Science Translational Medicine
Imaging Primer on Chimeric Antigen Receptor T-Cell Therapy for Radiologists | RadioGraphics
CMS Restructured The CAR-T DRG What It Means For Manufacturers 4 Strategies Forward
Quality risk management of the chimeric antigen receptor T cell pharmaceutical circuit in one of the first qualified European centers - Cytotherapy
CMS: Medicare will begin to cover CAR T-cell therapies in some facilities | Fierce Healthcare
CAR T cell immunotherapy for human cancer | Science
MM12928 - National Coverage Determination 110.24: Chimeric Antigen Receptor T-cell Therapy
Toxicity and management in CAR T-cell therapy: Molecular Therapy - Oncolytics
Challenges and Prospects of Chimeric Antigen Receptor T-cell Therapy for Metastatic Prostate Cancer - European Urology
CMS Finalizes New Reimbursement Method for CAR-T Treatments | Avalere Health
CMS, Hospitals, and the Future of CAR T-cell Therapy – CareSet Systems
CMS finalizes CAR T-cell therapy inpatient payments | Journal of Clinical Outcomes Management
Cardiovascular Effects of CAR T Cell Therapy: A Retrospective Study | JACC: CardioOncology
The CAR T‐Cell Mechanoimmunology at a Glance - Li - 2020 - Advanced Science - Wiley Online Library
Synthetic Biology in Chimeric Antigen Receptor T (CAR T) Cell Engineering | ACS Synthetic Biology
Systematic review of nutrition support interventions in adult haematology and oncology patients receiving CAR T cell therapy - Clinical Nutrition ESPEN
Chemically Programmable and Switchable CAR‐T Therapy - Qi - 2020 - Angewandte Chemie International Edition - Wiley Online Library
In vivo imaging of nanoparticle-labeled CAR T cells | PNAS
CAR T-cell therapy for multiple myeloma: state of the art and prospects - The Lancet Haematology
Accelerating clinical-scale production of BCMA CAR T cells with defined maturation stages: Molecular Therapy - Methods & Clinical Development
CAR T-cell therapy: opportunities and challenges | Immunotherapy
CAR-T design: Elements and their synergistic function - eBioMedicine
CAR-T Reimbursement in the US - Challenges and an Assessment of Potential Solutions - groupH
